BMI vs REGN · P/E 29, rev $205.2M vs P/E 14, rev $14.34B
Badger Meter Inc (BMI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Badger Meter Inc (BMI) is a scientific & technical instruments company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BMI revenue for 2024-12-31 was $205.2M. Net income was $30.7M. Revenue was down 1.6% from 2024-09-30 to 2024-12-31. BMI currently screens at market cap $3.69B and trailing P/E 28.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BMI currently screens at market cap $3.69B and trailing P/E 28.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BMI and REGN stock pages for the full models.
Not investment advice.